Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Alternative anti-CD20 antibody versus desensitization for lymphoma patients with drug hypersensitivity reactions requiring discontinuation of rituximab, obinutuzumab, or ofatumumab
    Meeting Abstract

    Ghione, P.; Joffe, E.; De Paola, N.; Mainardi, T.; Noor, S. J.; Bobillo, S.; Myskowski, P. L.; Palomba, M. L.; Moskowitz, A. J.; Mato, A. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Ivosidenib (IVO) prior to hematopoietic cell transplant for patients with IDH1-mutant relapsed or refractory acute myeloid leukemia (R/R AML)
    Meeting Abstract

    Dinardo, C. D.; Stein, E.; Pigneux, A.; Altman, J. K.; Collins, R.; Erba, H. P.; Watts, J. M.; Uy, G. L.; Kapsalis, S. M.; Liu, H.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Effect of enasidenib (ENA) plus azacitidine (AZA) on complete remission and overall response versus AZA monotherapy in mutant-IDH2 (mIDH2) newly diagnosed acute myeloid leukemia (ND-AML)
    Meeting Abstract

    Dinardo, C. D.; Schuh, A. C.; Stein, E. M.; Montesinos, P.; Wei, A.; De Botton, S.; Zeidan, A. M.; Fathi, A. T.; Quek, L.; Kantarjian, H. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Interim analysis (IA) of OPTIC: A dose-ranging study of three ponatinib (PON) starting doses
    Meeting Abstract

    Cortes, J. E.; Lomaia, E.; Turkina, A.; Moiraghi, B.; Sutton, M. U.; Pavlovsky, C.; Rojas, C.; Chuah, C.; Arthur, C. K.; Apperley, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Evaluating the association between clonal hematopoiesis and germline pathogenic and likely pathogenic variants in cancer predisposition genes
    Meeting Abstract

    Comen, E. A.; Razavi, P.; Patel, P. B.; Martin, A.; Seshan, V. E.; Mandelker, D.; Ptashkin, R.; Kemel, Y.; Stadler, Z. K.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • The impact of poly ADP ribose polymerase (PARP) inhibitors on clonal hematopoiesis
    Meeting Abstract

    Bolton, K. L.; Moukarzel, L. A.; Ptashkin, R.; Gao, T.; Patel, M.; Caltabellotta, N.; Braunstein, L. Z.; Aghajanian, C.; Hyman, D. M.; Berger, M. F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Leukemia cell of origin influences apoptotic priming and sensitivity to LSD1 inhibition
    Journal Article

    Cai, S. F.; Chu, S. H.; Goldberg, A. D.; Parvin, S.; Koche, R. P.; Glass, J. L.; Stein, E. M.; Tallman, M. S.; Sen, F.; Famulare, C. A.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Outcomes of COVID-19 in patients with CLL: A multicenter international experience
    Journal Article

    Mato, A. R.; Roeker, L. E.; Lamanna, N.; Allan, J. N.; Leslie, L.; Pagel, J. M.; Patel, K.; Osterborg, A.; Wojenski, D.; Kamdar, M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia—A systematic review and meta-analysis
    Review

    Bewersdorf, J. P.; Giri, S.; Tallman, M. S.; Zeidan, A. M.; Stahl, M.
    Transfusion (2020)

    Fulltext@MSK | Save
  • Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
    Research Letter

    Bernard, E.; Nannya, Y.; Hasserjian, R. P.; Devlin, S. M.; Tuechler, H.; Medina-Martinez, J. S.; Yoshizato, T.; Shiozawa, Y.; Saiki, R.; Malcovati, L.; more...
    Nature Medicine (2020)

    Fulltext@MSK | Save